Search

Author/Creator Chen, Luohai

1. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms. Issue 10 (November 2020)

Authors:
Shi, Huiying; Chen, Luohai; Zhang, Qin; Lin, Yuan; Jiang, Chen; Yao, Hailing; Hou, Xiaohua; Chen, Minhu; Lin, Rong; Chen, Jie
Journal:
Pancreas
Issue:
Volume 49:Issue 10(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Single centre retrospective review of outcome of 177Lu‐DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors. (18th November 2022)

Authors:
Alsadik, Shahad; Gnanasegaran, Gopinath; Chen, Luohai; Quigley, Ann‐Marie; Mandair, Dalvinder; Toumpanakis, Christos; Caplin, Martyn; Navalkissoor, Shaunak
Journal:
Journal of neuroendocrinology
Issue:
Volume 34:Number 11(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors. Issue 1 (7th October 2022)

Authors:
Chen, Luohai; Wang, Wei; Jin, Kaizhou; Yuan, Bing; Tan, Huangying; Sun, Jian; Guo, Yu; Luo, Yanji; Feng, Shi‐Ting; Yu, Xianjun; Chen, Min‐Hu; Chen, Jie
Other Names:
Qin Shuqui guestEditor.; Li Jin guestEditor.; Guo Jun guestEditor.; Ma Jun guestEditor.; Zhou Caicun guestEditor.
Journal:
International journal of cancer
Issue:
Volume 152:Issue 1(2023)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗